Profile
Dr. Lars Kåre Viksmoen, MD, is an Independent Director at PCI Biotech Holding ASA. He is on the Board of Directors at PCI Biotech Holding ASA and Labrida AS.
Dr. Viksmoen was previously employed as an Independent Director by Veloxis Pharmaceuticals A/S, a President & Chief Executive Officer by GN ReSound A/S, a Member-Executive Management by GN Store Nord A/S, a Chief Executive Officer by Biotec Pharmacon ASA, a Vice President & Regional Director-Europe by Merck & Co., Inc., and a Managing Director by MSD (Norge) AS.
He received his doctorate degree from the University of Oslo.
Lars Kåre Viksmoen active positions
| Companies | Position | Start |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Director/Board Member | 2016-04-30 |
Labrida AS
Labrida AS Medical SpecialtiesHealth Technology Develops and wholesales products for maintenance treatment of dental implants | Director/Board Member | - |
Former positions of Lars Kåre Viksmoen
| Companies | Position | End |
|---|---|---|
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Chief Executive Officer | 2014-07-31 |
| GN STORE NORD A/S | Corporate Officer/Principal | 2014-07-31 |
| ARCTICZYMES TECHNOLOGIES ASA | President | 2010-02-28 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2006-08-31 |
MSD (Norge) AS
MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | President | 1991-12-31 |
Training of Lars Kåre Viksmoen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
PCI Biotech Holding ASA
PCI Biotech Holding ASA BiotechnologyHealth Technology Develops photochemical drug delivery technology for use in therapeutic treatment | Health Technology |
GN Store Nord A/S
GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MSD (Norge) AS
MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Labrida AS
Labrida AS Medical SpecialtiesHealth Technology Develops and wholesales products for maintenance treatment of dental implants | Health Technology |
- Stock Market
- Insiders
- Lars Kåre Viksmoen
















